JP2011105644A - Melanin uptake inhibitor - Google Patents
Melanin uptake inhibitor Download PDFInfo
- Publication number
- JP2011105644A JP2011105644A JP2009262309A JP2009262309A JP2011105644A JP 2011105644 A JP2011105644 A JP 2011105644A JP 2009262309 A JP2009262309 A JP 2009262309A JP 2009262309 A JP2009262309 A JP 2009262309A JP 2011105644 A JP2011105644 A JP 2011105644A
- Authority
- JP
- Japan
- Prior art keywords
- parts
- melanin
- melanin uptake
- uptake inhibitor
- extraction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 title claims abstract description 88
- 239000003112 inhibitor Substances 0.000 title claims abstract description 20
- 239000000284 extract Substances 0.000 claims abstract description 27
- 241000196324 Embryophyta Species 0.000 claims abstract description 21
- 235000006468 Thea sinensis Nutrition 0.000 claims abstract description 20
- 244000194101 Ginkgo biloba Species 0.000 claims abstract description 19
- 235000008100 Ginkgo biloba Nutrition 0.000 claims abstract description 19
- 235000020333 oolong tea Nutrition 0.000 claims abstract description 18
- 241000220317 Rosa Species 0.000 claims description 17
- 244000269722 Thea sinensis Species 0.000 claims description 17
- 235000011201 Ginkgo Nutrition 0.000 claims description 15
- 235000013616 tea Nutrition 0.000 claims description 15
- 235000009508 confectionery Nutrition 0.000 claims description 13
- 235000005340 Asparagus officinalis Nutrition 0.000 claims description 11
- 244000003416 Asparagus officinalis Species 0.000 claims description 4
- 241000219227 Acer japonicum Species 0.000 claims 1
- 241000931515 Acer palmatum Species 0.000 abstract description 21
- 241000219422 Urtica Species 0.000 abstract description 18
- 230000002401 inhibitory effect Effects 0.000 abstract description 14
- 235000009008 Eriobotrya japonica Nutrition 0.000 abstract description 10
- 239000004480 active ingredient Substances 0.000 abstract description 9
- 235000008694 Humulus lupulus Nutrition 0.000 abstract description 5
- 244000025221 Humulus lupulus Species 0.000 abstract description 5
- 235000008658 Artemisia capillaris Nutrition 0.000 abstract description 3
- 241000092668 Artemisia capillaris Species 0.000 abstract description 3
- 240000006914 Aspalathus linearis Species 0.000 abstract description 3
- 235000012984 Aspalathus linearis Nutrition 0.000 abstract description 3
- 244000061508 Eriobotrya japonica Species 0.000 abstract description 3
- 240000000691 Houttuynia cordata Species 0.000 abstract description 3
- 235000013719 Houttuynia cordata Nutrition 0.000 abstract description 3
- 241000086254 Arnica montana Species 0.000 abstract description 2
- 235000003884 Aspalathus contaminatus Nutrition 0.000 abstract description 2
- 241001357959 Hydrangea serrata Species 0.000 abstract description 2
- 244000052585 Rosa centifolia Species 0.000 abstract description 2
- 235000016588 Rosa centifolia Nutrition 0.000 abstract description 2
- 235000017089 Scutellaria baicalensis Nutrition 0.000 abstract description 2
- 240000004534 Scutellaria baicalensis Species 0.000 abstract description 2
- 244000081822 Uncaria gambir Species 0.000 abstract description 2
- 241000400007 Uncarina Species 0.000 abstract description 2
- 239000000126 substance Substances 0.000 abstract description 2
- 235000017519 Artemisia princeps Nutrition 0.000 abstract 1
- 244000065027 Artemisia princeps Species 0.000 abstract 1
- 238000000605 extraction Methods 0.000 description 33
- 239000002994 raw material Substances 0.000 description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 18
- 235000009108 Urtica dioica Nutrition 0.000 description 16
- 238000011282 treatment Methods 0.000 description 11
- 239000000470 constituent Substances 0.000 description 10
- 239000000203 mixture Substances 0.000 description 10
- 239000002904 solvent Substances 0.000 description 10
- 241000234427 Asparagus Species 0.000 description 7
- 241001092070 Eriobotrya Species 0.000 description 7
- 210000003491 skin Anatomy 0.000 description 7
- 241000208983 Arnica Species 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 206010057249 Phagocytosis Diseases 0.000 description 4
- 208000012641 Pigmentation disease Diseases 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 235000013399 edible fruits Nutrition 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 210000002780 melanosome Anatomy 0.000 description 4
- 230000008782 phagocytosis Effects 0.000 description 4
- 230000002265 prevention Effects 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- 235000003826 Artemisia Nutrition 0.000 description 3
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 3
- 240000008620 Fagopyrum esculentum Species 0.000 description 3
- 241000218228 Humulus Species 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 244000086363 Pterocarpus indicus Species 0.000 description 3
- 235000009984 Pterocarpus indicus Nutrition 0.000 description 3
- 240000008866 Ziziphus nummularia Species 0.000 description 3
- -1 aliphatic alcohols Chemical class 0.000 description 3
- 244000030166 artemisia Species 0.000 description 3
- 235000009052 artemisia Nutrition 0.000 description 3
- 210000002510 keratinocyte Anatomy 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000011259 mixed solution Substances 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 239000002953 phosphate buffered saline Substances 0.000 description 3
- 239000002798 polar solvent Substances 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 150000005846 sugar alcohols Polymers 0.000 description 3
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 241001573881 Corolla Species 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 244000267823 Hydrangea macrophylla Species 0.000 description 2
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 2
- 241000238633 Odonata Species 0.000 description 2
- 241000209504 Poaceae Species 0.000 description 2
- 235000004789 Rosa xanthina Nutrition 0.000 description 2
- 241000220222 Rosaceae Species 0.000 description 2
- 241000592344 Spermatophyta Species 0.000 description 2
- 102000003425 Tyrosinase Human genes 0.000 description 2
- 108060008724 Tyrosinase Proteins 0.000 description 2
- 239000012752 auxiliary agent Substances 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 235000018597 common camellia Nutrition 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000005238 degreasing Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 210000001339 epidermal cell Anatomy 0.000 description 2
- 210000005175 epidermal keratinocyte Anatomy 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 238000005342 ion exchange Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 210000004694 pigment cell Anatomy 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 239000012264 purified product Substances 0.000 description 2
- 230000014639 sexual reproduction Effects 0.000 description 2
- 241000894007 species Species 0.000 description 2
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- 244000235603 Acacia catechu Species 0.000 description 1
- 235000006020 Acacia catechu Nutrition 0.000 description 1
- 241000208140 Acer Species 0.000 description 1
- 241000233788 Arecaceae Species 0.000 description 1
- 244000286893 Aspalathus contaminatus Species 0.000 description 1
- 241000209507 Camellia Species 0.000 description 1
- 240000001548 Camellia japonica Species 0.000 description 1
- 244000260524 Chrysanthemum balsamita Species 0.000 description 1
- 235000005633 Chrysanthemum balsamita Nutrition 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- AHMIDUVKSGCHAU-UHFFFAOYSA-N Dopaquinone Natural products OC(=O)C(N)CC1=CC(=O)C(=O)C=C1 AHMIDUVKSGCHAU-UHFFFAOYSA-N 0.000 description 1
- 241000380130 Ehrharta erecta Species 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- 235000014486 Hydrangea macrophylla Nutrition 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 241000721662 Juniperus Species 0.000 description 1
- AHMIDUVKSGCHAU-LURJTMIESA-N L-dopaquinone Chemical compound [O-]C(=O)[C@@H]([NH3+])CC1=CC(=O)C(=O)C=C1 AHMIDUVKSGCHAU-LURJTMIESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 241000207923 Lamiaceae Species 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000237536 Mytilus edulis Species 0.000 description 1
- 240000004371 Panax ginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 241001107098 Rubiaceae Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 241000190021 Zelkova Species 0.000 description 1
- 244000126002 Ziziphus vulgaris Species 0.000 description 1
- 239000001560 acacia catechu Substances 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000000043 antiallergic agent Substances 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 238000004042 decolorization Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000004332 deodorization Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- RXKJFZQQPQGTFL-UHFFFAOYSA-N dihydroxyacetone Chemical compound OCC(=O)CO RXKJFZQQPQGTFL-UHFFFAOYSA-N 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000013505 freshwater Substances 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000004005 microsphere Substances 0.000 description 1
- 208000015994 miscarriage Diseases 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000003068 molecular probe Substances 0.000 description 1
- 235000020638 mussel Nutrition 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 239000012454 non-polar solvent Substances 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 239000010330 ougon Substances 0.000 description 1
- 238000012261 overproduction Methods 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 235000020330 rooibos tea Nutrition 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 239000002349 well water Substances 0.000 description 1
- 235000020681 well water Nutrition 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
本発明は、メラニン取込抑制剤に関する。 The present invention relates to a melanin uptake inhibitor.
皮膚においてメラニンは、紫外線から生体を保護する役目も果たしているが、過剰生成や不均一な蓄積は、皮膚の黒化やシミの原因となる。一般にメラニンは、色素細胞の中で生合成される酵素チロシナーゼの働きによって、チロシンからドーパ、ドーパからドーパキノンに変化し、ついで5,6−ジヒドロキシインドフェノール等の中間体を経て形成されるものとされている。 Melanin also plays a role in protecting the body from ultraviolet rays in the skin, but overproduction and uneven accumulation cause skin darkening and spots. In general, melanin is converted from tyrosine to dopa and from dopa to dopaquinone by the action of the enzyme tyrosinase biosynthesized in pigment cells, and then formed through intermediates such as 5,6-dihydroxyindophenol. ing.
そのため、従来は、皮膚の色黒(皮膚色素沈着症)、シミ、ソバカス等を予防、治療又は改善するために、メラニンの産生に関与するチロシナーゼの活性を阻害する成分、又はメラニンの産生を抑制する成分の開発に注力されてきている(特許文献1〜4参照)。 Therefore, conventionally, in order to prevent, treat, or improve skin darkness (skin pigmentation), spots, buckwheat, etc., it inhibits the activity of tyrosinase involved in the production of melanin, or suppresses the production of melanin Has been focused on the development of the components (see Patent Documents 1 to 4).
一方、上記のようにして形成されるメラニンは、色素細胞におけるメラノソーム(小胞)において合成・貯蔵され、ファゴサイトーシス(貪食作用)によって表皮細胞(ケラチノサイト)にメラノソームとして取り込まれることで、表皮が黒化することが知られている(特許文献5参照)。したがって、表皮細胞(ケラチノサイト)におけるメラノソームの取り込みを抑制することができれば、皮膚の色黒(皮膚色素沈着症)、シミ、ソバカス等を予防、治療又は改善することができると考えられる。 On the other hand, the melanin formed as described above is synthesized and stored in melanosomes (vesicles) in pigment cells, and is taken up as epithelial cells (keratinocytes) as melanosomes by phagocytosis (phagocytosis). It is known to blacken (see Patent Document 5). Therefore, if the uptake of melanosomes in epidermal cells (keratinocytes) can be suppressed, it is considered that skin darkness (skin pigmentation), spots, freckles, etc. can be prevented, treated or improved.
本発明は、天然物の中から安全性が高く、安価で日常的に使用可能であり、かつ優れたメラニン取込抑制作用を有するものを見出し、それを有効成分として含有するメラニン取込抑制剤を提供することを目的とする。 The present invention finds a natural product that is safe and inexpensive, can be used on a daily basis, and has an excellent melanin uptake inhibitory effect, and contains it as an active ingredient. The purpose is to provide.
本発明は、イロハモミジ、アスパラサスリネアリス、ガイヨウ、ウーロン茶、インチンコウ、オウゴン、アルニカ、セイヨウバラ、イチョウ、ジュウヤク、ビワ、ホップ、アセンヤク、甘茶及びイラクサからなる群より選ばれる1種又は2種以上の植物からの抽出物を有効成分として含有することを特徴とするメラニン取込抑制剤を提供する。 The present invention relates to one or more kinds of plants selected from the group consisting of Japanese maple, Asparagus serie Alice, Guillain, Oolong tea, Inchinkou, Ogon, Arnica, Atlantic rose, Ginkgo biloba, Juniper, Loquat, Hops, Acacia, Sweet tea and Nettle. A melanin uptake inhibitor comprising an extract from the above as an active ingredient.
本発明によれば、安全性が高く、安価で日常的に使用可能であり、かつ優れたメラニン取込抑制作用を有するメラニン取込抑制剤を提供することができる。 According to the present invention, it is possible to provide a melanin uptake inhibitor that has high safety, is inexpensive and can be used on a daily basis, and has an excellent action of suppressing melanin uptake.
以下、本発明の実施の形態を説明する。
本実施形態のメラニン取込抑制剤は、イロハモミジ、アスパラサスリネアリス、ガイヨウ、ウーロン茶、インチンコウ、オウゴン、アルニカ、セイヨウバラ、イチョウ、ジュウヤク、ビワ、ホップ、アセンヤク、甘茶及びイラクサからなる群より選ばれる1種又は2種以上の植物からの抽出物を有効成分として含有する。
Embodiments of the present invention will be described below.
The melanin uptake inhibitor of the present embodiment is 1 selected from the group consisting of Japanese maple, Asparasaslinearias, Guillain, Oolong tea, Inchinkou, Ogon, Arnica, Rosewood, Ginkgo, Jujuk, Biwa, Hop, Asenyaku, Sweet tea and Nettle. Extracts from seeds or two or more plants are contained as active ingredients.
本実施形態において「抽出物」には、植物を抽出原料として得られる抽出液、当該抽出液の希釈液若しくは濃縮液、当該抽出液を乾燥して得られる乾燥物、又はこれらの粗精製物若しくは精製物のいずれもが含まれる。 In the present embodiment, the “extract” includes an extract obtained by using a plant as an extraction raw material, a diluted solution or a concentrated solution of the extract, a dried product obtained by drying the extract, or a roughly purified product thereof. Any of the purified products are included.
本実施形態において使用する抽出原料は、イロハモミジ、アスパラサスリネアリス、ガイヨウ、ウーロン茶、インチンコウ、オウゴン、アルニカ、セイヨウバラ、イチョウ、ジュウヤク、ビワ、ホップ、アセンヤク、甘茶又はイラクサである。 Extraction raw materials used in the present embodiment are Japanese maple, asparagus linen alice, guinea, oolong tea, chinococcus, hornon, arnica, rose, ginkgo, jujuak, loquat, hop, asenyaku, sweet tea or nettle.
イロハモミジ(学名:Acer palmatum)は、カエデ科カエデ属に属する落葉亜高木であって、イロハカエデ、タカオモミジ、タカオカエデ等とも呼ばれる。また、イロハモミジは、四国、九州、朝鮮南部、中国東部などに分布しており、これらの地域から容易に入手可能である。抽出原料として用いるイロハモミジの構成部位は特に限定されるものではなく、例えば、葉部、枝部、根部、樹皮部、種子部又はこれらの部位の混合物等が挙げられるが、好ましくは葉部である。 Acer palmatum (scientific name: Acer palmatum) is a deciduous sub-high tree belonging to the genus Acer palmaceae, and is also referred to as Acer palmatum, Acer palmatum, Aca palmae and the like. Japanese maple is distributed in Shikoku, Kyushu, southern Korea, eastern China, etc., and is easily available from these regions. The constituent part of the Japanese maple used as the extraction raw material is not particularly limited, and examples thereof include a leaf part, a branch part, a root part, a bark part, a seed part, or a mixture of these parts, preferably a leaf part. .
アスパラサスリネアリス(学名:Aspalathus linearis,別名:ルイボス)は、南アフリカ共和国のセダルバーグ山脈一帯のみに自生しているマメ科アスパラサス属に属する落葉低木であって、この地域から入手可能である。抽出原料として用いるアスパラサスリネアリスの構成部位は特に限定されるものではなく、例えば、葉部、枝部、幹部、樹皮部、根部又はこれらの部位の混合物等が挙げられるが、好ましくは葉部である。なお、アスパラサスリネアリスの葉部の乾燥物は、ルイボスティーの茶葉として広く用いられている。 Asparathus lineis (scientific name: Aspalathus linearis, also known as Rooibos) is a deciduous shrub belonging to the genus Asparathus, which grows only in the Sedelberg Mountains of South Africa, and is available from this region. There are no particular restrictions on the constituent parts of Asparagus lineias used as the raw material for extraction, and examples include leaf parts, branch parts, trunk parts, bark parts, root parts, or a mixture of these parts. is there. In addition, the dried material of the leaf part of Asparasa linenalice is widely used as tea leaves of Rooibos tea.
ガイヨウ(生薬名)は、日本全土に分布しているキク科ヨモギ属に属する多年生草本であるヨモギ(学名:Artemisia priceps Pampanini)の葉部であり、これらの地域から容易に入手することができる。ガイヨウは、従来、婦人科領域の止血、流産防止、寒証の腹痛の予防等に使用されている。 Gaiyou (name of crude drug) is a leaf part of artemisia (Artemisia priceps Pampanini), a perennial herb belonging to the genus Artemisia, which is distributed throughout Japan, and can be easily obtained from these regions. Conventionally, gaiyo has been used for hemostasis in the gynecological field, prevention of miscarriage and prevention of cold abdominal pain.
ウーロン茶とは、チャ(学名:Camellia sinensis)の葉部を半発酵させたものをいう。チャ(Camellia sinensis)は、中国、インド、日本等に分布しているツバキ科ツバキ属に属する常緑小低木であり、これらの地域から容易に入手することができる。 Oolong tea is tea (scientific name: Camellia sinensis) leaves that are semi-fermented. Cha (Camellia sinensis) is an evergreen small shrub belonging to the genus Camellia that is distributed in China, India, Japan, etc., and can be easily obtained from these areas.
インチンコウ(生薬名)は、北海道、本州、四国、九州等に分布している多年草であるキク科ヨモギ属に属するカワラヨモギ(学名:Artemisia capillaris)の花部であり、これらの地域から容易に入手することができる。インチンコウは、従来、黄疸の治療、強壮薬等として使用されている。 Inchinkou (name of herbal medicine) is a flower part of the genus Artemisia capillaris belonging to the genus Artemisia capillaris which is a perennial plant distributed in Hokkaido, Honshu, Shikoku, Kyushu, etc., and is easily obtained from these areas be able to. Inchinkou has been conventionally used as a treatment for jaundice, a tonic, and the like.
オウゴン(生薬名)は、中国北部から東北部、モンゴル等に分布しているシソ科タツナミソウ属に属する多年草であるコガネバナ(学名:Scutellaria baicalensis Georgi)の根部であり、これらの地域から容易に入手することができる。オウゴンは、従来、健胃薬、抗アレルギー剤等として使用されている。 Ogon (herbal medicine) is the root part of the perennial grass, Scutellaria baicalensis Georgi, belonging to the genus Lamiaceae that is distributed in northern China, northeastern part, Mongolia, etc., and is easily obtained from these regions be able to. Ougon is conventionally used as a stomachic medicine, an antiallergic agent and the like.
アルニカ(学名:Arnica montana L.)は、ヨーロッパから南ロシアまでの山岳地方の酸性土壌の牧草地に生育するヒナギク(daisy)に似たキク科ウサギギク属に属する多年草であり、これらの地域から容易に入手することができる。抽出原料として使用し得るアルニカの構成部位としては、例えば、幹部、地上部、花部、根部、全草等が挙げられるが、好ましくは花部である。 Arnica (scientific name: Arnica montana L.) is a perennial plant belonging to the genus Rabbitaceae that resembles daisy that grows on acid soil meadows in mountainous regions from Europe to Southern Russia. Can be obtained. Arnica constituent parts that can be used as the raw material for extraction include, for example, trunk, above-ground parts, flower parts, root parts, whole grasses, etc., preferably flower parts.
なお、「花」とは、一般に種子植物の有性生殖にかかわる器官の総体をいい、葉の変形である花葉と、茎の変形である花軸とから構成され、花葉には、萼、花弁、オシベ、心皮等の器官が含まれる。本実施形態において抽出原料として使用し得る「花部」には、種子植物の有性生殖にかかわる器官の総体の他、その一部、例えば、花葉、花被(萼と花冠)、花冠、花弁等も含まれる。 The term “flower” generally refers to the whole organ involved in sexual reproduction of a seed plant, and is composed of a flower leaf that is a leaf deformation and a flower axis that is a stem deformation. , Organs such as petals, oshibe, and heart skin. In the present embodiment, the “floral part” that can be used as the raw material for extraction includes, in addition to the total organs involved in sexual reproduction of seed plants, a part thereof, for example, flower leaves, flower coats (buds and corolla), corolla, Also includes petals.
セイヨウバラ(学名:Rosa centifolia)は、アジアからヨーロッパ等で広く栽培されているバラ科バラ属に属する植物であって、これらの地域から容易に入手することができる。抽出原料として使用し得るセイヨウバラの構成部位としては、例えば、花部、葉部、茎部等が挙げられるが、好ましくは花部である。 Rose rose (scientific name: Rosa centifolia) is a plant belonging to the genus Rosaceae that is widely cultivated in Asia from Europe and can be easily obtained from these regions. Examples of the constituent parts of the rose that can be used as an extraction raw material include a flower part, a leaf part, a stem part, and the like, and a flower part is preferable.
イチョウ(学名:Ginkgo biloba L.)は、北海道、本州、四国、九州等に自生するイチョウ科イチョウ属に属する落葉高木であり、これらの地域から容易に入手することができる。抽出原料として使用するイチョウの構成部位としては、葉部、花部、根部、樹皮部、枝部又はこれらの部位の混合物等が挙げられるが、好ましくは葉部である。 Ginkgo (scientific name: Ginkgo biloba L.) is a deciduous tree belonging to the genus Ginkgo genus that grows naturally in Hokkaido, Honshu, Shikoku, Kyushu, etc., and can be easily obtained from these regions. Examples of the constituent parts of ginkgo biloba used as an extraction raw material include leaf parts, flower parts, root parts, bark parts, branch parts, or a mixture of these parts, with the leaf part being preferred.
ジュウヤク(学名:Houttuynia cordata Thunberg)は、日本の陰湿地に多く野生するドクダミ科ドクダミ属に属する多年生草本であり、これらの地域から容易に入手することができる。抽出原料として使用し得るジュウヤクの構成部位としては、例えば、葉部、枝部、樹皮部、幹部、茎部、果実部、種子部、花部等の地上部、根茎部又はこれらの部位の混合物が挙げられるが、好ましくは地上部である。 Zhuyak (scientific name: Houttuynia cordata Thunberg) is a perennial herb belonging to the genus Dokudami, which is abundant in the Japanese marsh, and can be easily obtained from these areas. Examples of the constituent parts of zelkova that can be used as an extraction raw material include, for example, leaf parts, branch parts, bark parts, trunk parts, stem parts, fruit parts, seed parts, flower parts and the like, rhizome parts, or a mixture of these parts. The above-mentioned part is preferable.
ビワ(学名:Eriobotrya japonica Lindley)は、バラ科ビワ属に属する常緑高木であり、中国南西部原産であり、長崎、千葉、鹿児島等で栽培されており、これらの地域から容易に入手することができる。抽出原料として使用し得る部位としては、例えば、葉部、幹部、枝部、花部、果実部、種子部、根部又はこれらの部位の混合物等が挙げられるが、好ましくは葉部である。ビワの葉部は、「名医別録」に収載され、古くから薬草として用いられてきた。葉の形が琵琶に似ているからその名が付いたといわれている。日本では江戸時代にこのビワの葉の毛を除去して乾燥したものを主剤とした煎じ薬を「枇杷薬湯」と称し、暑気払いに用いていた。 Biwa (scientific name: Eriobotrya japonica Lindley) is an evergreen tree belonging to the genus Biwa of the family Rosaceae, native to the southwestern part of China, and cultivated in Nagasaki, Chiba, Kagoshima, etc., and can be easily obtained from these areas it can. Examples of the part that can be used as the extraction raw material include a leaf part, a trunk part, a branch part, a flower part, a fruit part, a seed part, a root part, or a mixture of these parts, and a leaf part is preferable. The loquat of loquat is listed in the “Special Medical Supplement” and has long been used as a medicinal herb. It is said that the name is given because the shape of the leaf resembles a camellia. In Japan, in the Edo period, the decoction that was made by removing the loquat leaves and drying them was called “Yakuyaku-yu” and was used to remove heat.
ホップ(学名:Humulus lupulus)は、ヨーロッパ、北米等で広く栽培されているアサ科カラハナソウ属に属する多年草であり、これらの地域から容易に入手することができる。抽出原料として使用し得るホップの構成部位としては、例えば、葉部、根部、花部、茎部、雌花穂部又はこれらの部位の混合物等が挙げられるが、好ましくは雌花穂部である。 Hops (scientific name: Humulus lupulus) are perennials belonging to the genus Coleaceae that are widely cultivated in Europe, North America and the like, and can be easily obtained from these regions. Examples of the constituent parts of hops that can be used as an extraction raw material include leaf parts, root parts, flower parts, stem parts, female flower parts, or a mixture of these parts, but female flower parts are preferred.
アセンヤク(学名:Uncarina gambir)は、東南アジア等に分布しているアカネ科に属する植物であり、これらの地域から容易に入手可能である。抽出原料として使用するアセンヤクの構成部位としては、例えば、花(蕾)部、葉部、枝部、樹皮部、根部等が挙げられるが、好ましくは葉部である。 Asenyak (scientific name: Uncarina gambir) is a plant belonging to the Rubiaceae family that is distributed in Southeast Asia and the like, and is easily available from these regions. Examples of the constituent parts of Acacia catechu used as an extraction raw material include a flower (bud) part, a leaf part, a branch part, a bark part, a root part, and the like, and a leaf part is preferable.
アマチャ(学名:Hydrangea serrata)は、関東地方以西、四国、九州等に自生しているユキノシタ科アジサイ属に属する落葉小低木であり、これらの地域から容易に入手することができる。抽出原料として使用し得るアマチャの構成部位としては、例えば、葉部、茎部、花部、蕾部、果実部、果核部、地上部又はこれらの部位の混合物等が挙げられるが、好ましくは地上部である。 Achacha (scientific name: Hydrangea serrata) is a deciduous small shrub belonging to the genus Hydrangea hydrangea growing in the west of the Kanto region, Shikoku, Kyushu, etc., and can be easily obtained from these regions. Examples of the constituent parts of the armature that can be used as the raw material for extraction include leaf parts, stem parts, flower parts, cocoon parts, fruit parts, fruit core parts, above-ground parts, or a mixture of these parts. It is the ground part.
イラクサ(学名:Urtica thubergiana)は、日本の本州、四国、九州、朝鮮半島等に分布しているイラクサ科イラクサ属に属する多年生草本であり、これらの地域から容易に入手することができる。抽出原料として使用し得るイラクサの構成部位としては、例えば、葉部、茎部、花部、根部、根皮部、地上部、全草又はこれらの部位の混合物等が挙げられるが、好ましくは葉部である。 Nettle (scientific name: Urtica thubergiana) is a perennial herb belonging to the genus Nettle that is distributed in Honshu, Shikoku, Kyushu, the Korean Peninsula, etc. in Japan, and can be easily obtained from these regions. Examples of the constituent parts of nettle that can be used as an extraction raw material include leaf parts, stem parts, flower parts, root parts, root bark parts, above-ground parts, whole grasses, or a mixture of these parts, preferably leaves. Part.
イロハモミジ、アスパラサスリネアリス、ガイヨウ、ウーロン茶、インチンコウ、オウゴン、アルニカ、セイヨウバラ、イチョウ、ジュウヤク、ビワ、ホップ、アセンヤク、甘茶及びイラクサからなる群より選ばれる1種又は2種以上の植物からの抽出物に含有されるメラニン取込抑制作用を有する物質の詳細は不明であるが、植物の抽出に一般に用いられている抽出方法によってこれらの植物からメラニン取込抑制作用を有する抽出物を得ることができる。 Extracts from one or more plants selected from the group consisting of Japanese maple, Asparagus serie Alice, Guillain, Oolong tea, Inchinkou, Ogon, Arnica, Rose of rose, Ginkgo, Jujuk, Biwa, Hop, Asenya, Sweet tea and Nettle Although the details of the substance having an inhibitory action on melanin uptake contained in potato are unknown, extracts having an inhibitory action on melanin uptake can be obtained from these plants by an extraction method generally used for extraction of plants. .
上記抽出物は、抽出原料を乾燥した後、そのまま又は粗砕機を用いて粉砕し、抽出溶媒による抽出に供することにより得ることができる。乾燥は天日で行ってもよいし、通常使用される乾燥機を用いて行ってもよい。また、ヘキサン等の非極性溶媒によって脱脂等の前処理を施してから抽出原料として使用してもよい。脱脂等の前処理を行うことにより、植物の極性溶媒による抽出処理を効率よく行うことができる。 The above extract can be obtained by drying the raw material for extraction and then pulverizing the raw material as it is or using a crusher and subjecting it to extraction with an extraction solvent. Drying may be performed in the sun or using a commonly used dryer. Moreover, after performing pretreatment, such as degreasing, with a nonpolar solvent such as hexane, it may be used as an extraction raw material. By performing pretreatment such as degreasing, extraction treatment with a polar solvent of a plant can be performed efficiently.
抽出溶媒としては、極性溶媒を使用するのが好ましく、例えば、水、親水性有機溶媒等が挙げられ、これらを単独で又は2種以上を組み合わせて、室温又は溶媒の沸点以下の温度で使用するのが好ましい。 As the extraction solvent, it is preferable to use a polar solvent, and examples thereof include water and hydrophilic organic solvents. These are used alone or in combination of two or more at room temperature or a temperature below the boiling point of the solvent. Is preferred.
抽出溶媒として使用し得る水としては、純水、水道水、井戸水、鉱泉水、鉱水、温泉水、湧水、淡水等のほか、これらに各種処理を施したものが含まれる。水に施す処理としては、例えば、精製、加熱、殺菌、濾過、イオン交換、浸透圧調整、緩衝化等が含まれる。したがって、本実施形態において抽出溶媒として使用し得る水には、精製水、熱水、イオン交換水、生理食塩水、リン酸緩衝液、リン酸緩衝生理食塩水等も含まれる。 Examples of water that can be used as the extraction solvent include pure water, tap water, well water, mineral spring water, mineral water, hot spring water, spring water, fresh water, and the like, and those subjected to various treatments. Examples of the treatment applied to water include purification, heating, sterilization, filtration, ion exchange, osmotic pressure adjustment, buffering, and the like. Therefore, the water that can be used as the extraction solvent in this embodiment includes purified water, hot water, ion exchange water, physiological saline, phosphate buffer, phosphate buffered saline, and the like.
抽出溶媒として使用し得る親水性有機溶媒としては、メタノール、エタノール、プロピルアルコール、イソプロピルアルコール等の炭素数1〜5の低級脂肪族アルコール;アセトン、メチルエチルケトン等の低級脂肪族ケトン;1,3−ブチレングリコール、プロピレングリコール、グリセリン等の炭素数2〜5の多価アルコール等が挙げられる。 Examples of hydrophilic organic solvents that can be used as extraction solvents include lower aliphatic alcohols having 1 to 5 carbon atoms such as methanol, ethanol, propyl alcohol, and isopropyl alcohol; lower aliphatic ketones such as acetone and methyl ethyl ketone; 1,3-butylene. Examples thereof include polyhydric alcohols having 2 to 5 carbon atoms such as glycol, propylene glycol and glycerin.
2種以上の極性溶媒の混合液を抽出溶媒として使用する場合、その混合比は適宜調整することができる。例えば、水と低級脂肪族アルコールとの混合液を使用する場合には、水10容量部に対して低級脂肪族アルコール1〜90容量部を混合することが好ましく、水と低級脂肪族ケトンとの混合液を使用する場合には、水10容量部に対して低級脂肪族ケトン1〜40容量部を混合することが好ましく、水と多価アルコールとの混合液を使用する場合には、水10容量部に対して多価アルコール10〜90容量部を混合することが好ましい。 When using the liquid mixture of 2 or more types of polar solvents as an extraction solvent, the mixing ratio can be adjusted suitably. For example, when using a mixed solution of water and a lower aliphatic alcohol, it is preferable to mix 1 to 90 parts by volume of a lower aliphatic alcohol with respect to 10 parts by volume of water. When using a mixed solution, it is preferable to mix 1 to 40 parts by volume of a lower aliphatic ketone with 10 parts by volume of water, and when using a mixed solution of water and a polyhydric alcohol, water 10 It is preferable to mix 10 to 90 parts by volume of a polyhydric alcohol with respect to the volume part.
抽出処理は、抽出原料に含まれる可溶性成分を抽出溶媒に溶出させ得る限り特に限定はされず、常法に従って行うことができる。例えば、抽出原料の5〜15倍量(質量比)の抽出溶媒に、抽出原料を浸漬し、常温又は還流加熱下で可溶性成分を抽出させた後、濾過して抽出残渣を除去することにより抽出液を得ることができる。得られた抽出液から溶媒を留去するとペースト状の濃縮物が得られ、この濃縮物をさらに乾燥すると乾燥物が得られる。 The extraction treatment is not particularly limited as long as the soluble component contained in the extraction raw material can be eluted in the extraction solvent, and can be performed according to a conventional method. For example, the extraction raw material is immersed in an extraction solvent 5 to 15 times (mass ratio) of the extraction raw material, the soluble components are extracted at room temperature or under reflux, and then filtered to remove the extraction residue. A liquid can be obtained. When the solvent is distilled off from the obtained extract, a paste-like concentrate is obtained, and when this concentrate is further dried, a dried product is obtained.
精製は、例えば、活性炭処理、吸着樹脂処理、イオン交換樹脂処理等により行うことができる。得られたイロハモミジ、アスパラサスリネアリス、ガイヨウ、ウーロン茶、インチンコウ、オウゴン、アルニカ、セイヨウバラ、イチョウ、ジュウヤク、ビワ、ホップ、アセンヤク、甘茶及びイラクサからなる群より選ばれる1種又は2種以上の植物からの抽出液はそのままでもメラニン取込抑制剤の有効成分として使用することができるが、濃縮液又は乾燥物としたものの方が使用しやすい。 Purification can be performed by, for example, activated carbon treatment, adsorption resin treatment, ion exchange resin treatment, or the like. From one or two or more plants selected from the group consisting of the obtained Japanese maple, asparagus serie alice, mussel, oolong tea, inchinkou, dragonfly, arnica, rose, ginkgo, jujube, loquat, hops, asenyaku, sweet tea and nettle Although this extract can be used as it is as an active ingredient of the melanin uptake inhibitor, a concentrated solution or a dried product is easier to use.
イロハモミジ、アスパラサスリネアリス、ガイヨウ、ウーロン茶、インチンコウ、オウゴン、アルニカ、セイヨウバラ、イチョウ、ジュウヤク、ビワ、ホップ、アセンヤク、甘茶及びイラクサからなる群より選ばれる1種又は2種以上の植物からの抽出物は特有の匂いを有しているため、その生理活性の低下を招かない範囲で脱色、脱臭等を目的とする精製を行うことも可能であるが、皮膚化粧料等に配合する場合には大量に使用するものではないから、未精製のままでも実用上支障はない。 Extracts from one or more plants selected from the group consisting of Japanese maple, Asparagus serie Alice, Guillain, Oolong tea, Inchinkou, Ogon, Arnica, Rose of rose, Ginkgo, Jujuk, Biwa, Hop, Asenya, Sweet tea and Nettle Since it has a unique odor, it can be purified for the purpose of decolorization, deodorization, etc. within a range that does not cause a decrease in its physiological activity. Therefore, there is no practical problem even if it is not purified.
以上のようにして得られる、イロハモミジ、アスパラサスリネアリス、ガイヨウ、ウーロン茶、インチンコウ、オウゴン、アルニカ、セイヨウバラ、イチョウ、ジュウヤク、ビワ、ホップ、アセンヤク、甘茶及びイラクサからなる群より選ばれる1種又は2種以上の植物からの抽出物は、メラニン取込抑制作用を有しているため、その作用を利用してメラニン取込抑制剤の有効成分として使用することができる。 1 type or 2 selected from the group consisting of Acer palmatum, Asparagus Linea Alice, Guillain, Oolong tea, Inchinkou, Ogon, Arnica, Rose, Ginkgo, Jujube, Biwa, Hop, Asenya, Sweet tea and Nettle, obtained as described above Since the extract from the plant of a seed | species or more has a melanin uptake inhibitory action, it can be used as an active ingredient of a melanin uptake inhibitor using the action.
本実施形態のメラニン取込抑制剤は、イロハモミジ、アスパラサスリネアリス、ガイヨウ、ウーロン茶、インチンコウ、オウゴン、アルニカ、セイヨウバラ、イチョウ、ジュウヤク、ビワ、ホップ、アセンヤク、甘茶及びイラクサからなる群より選ばれる1種又は2種以上の植物からの抽出物のみからなるものでもよいし、上記抽出物を製剤化したものでもよい。 The melanin uptake inhibitor of the present embodiment is 1 selected from the group consisting of Japanese maple, Asparasaslinearias, Guillain, Oolong tea, Inchinkou, Ogon, Arnica, Rosewood, Ginkgo, Jujuk, Biwa, Hop, Asenyaku, Sweet tea and Nettle. It may consist only of extracts from seeds or two or more plants, or may be a formulation of the above extract.
本実施形態のメラニン取込抑制剤における、イロハモミジ、アスパラサスリネアリス、ガイヨウ、ウーロン茶、インチンコウ、オウゴン、アルニカ、セイヨウバラ、イチョウ、ジュウヤク、ビワ、ホップ、アセンヤク、甘茶及びイラクサからなる群より選ばれる1種又は2種以上の植物からの抽出物の含有量は、目的に応じて適宜設定することができる。また、上記抽出物のうちの2種以上を有効成分として用いる場合、それらの配合比は、それらの抽出物の有するメラニン取込抑制作用の程度に応じて、適宜調整すればよい。 In the melanin uptake inhibitor of this embodiment, 1 selected from the group consisting of Acer palmatum, Asparasaslinearias, Guillain, Oolong tea, Inchinkou, Ogon, Arnica, Rose, Ginkgo, Jujuk, Biwa, Hop, Asenyaku, Amacha and Nettle Content of the extract from a seed | species or 2 or more types of plants can be suitably set according to the objective. Moreover, when using 2 or more types of the said extract as an active ingredient, those compounding ratios should just adjust suitably according to the grade of the melanin uptake inhibitory action which those extracts have.
イロハモミジ、アスパラサスリネアリス、ガイヨウ、ウーロン茶、インチンコウ、オウゴン、アルニカ、セイヨウバラ、イチョウ、ジュウヤク、ビワ、ホップ、アセンヤク、甘茶及びイラクサからなる群より選ばれる1種又は2種以上の植物からの抽出物は、デキストリン、シクロデキストリン等の薬学的に許容し得るキャリアーその他任意の助剤を用いて、常法に従い、粉末状、顆粒状、液状等の任意の剤形に製剤化することができる。この際、助剤としては、例えば、賦形剤、安定剤、矯味・矯臭剤等を用いることができる。上記抽出物を製剤化したメラニン取込抑制剤の形態としては、例えば、軟膏剤、外用液剤、貼付剤等が挙げられる。 Extracts from one or more plants selected from the group consisting of Japanese maple, Asparagus serie Alice, Guillain, Oolong tea, Inchinkou, Ogon, Arnica, Rose of rose, Ginkgo, Jujuk, Biwa, Hop, Asenya, Sweet tea and Nettle Can be formulated into an arbitrary dosage form such as powder, granule, liquid and the like using a pharmaceutically acceptable carrier such as dextrin and cyclodextrin and any other auxiliary agent according to a conventional method. In this case, as an auxiliary agent, for example, an excipient, a stabilizer, a flavoring / flavoring agent, and the like can be used. Examples of the form of the melanin uptake inhibitor obtained by formulating the extract include ointments, external liquids, patches and the like.
なお、本実施形態のメラニン取込抑制剤は、必要に応じて、メラニン取込抑制作用を有する他の天然抽出物等を、イロハモミジ、アスパラサスリネアリス、ガイヨウ、ウーロン茶、インチンコウ、オウゴン、アルニカ、セイヨウバラ、イチョウ、ジュウヤク、ビワ、ホップ、アセンヤク、甘茶及びイラクサからなる群より選ばれる1種又は2種以上の植物からの抽出物とともに配合して有効成分として用いることができる。 In addition, the melanin uptake inhibitor of the present embodiment, if necessary, other natural extracts having a melanin uptake inhibitory action, such as Japanese maple, asparasaslinearias, gayyo, oolong tea, Inchinkou, Ogon, Arnica, Seiyo It can be blended with an extract from one or more plants selected from the group consisting of rose, ginkgo, jujube, loquat, hop, asenya, sweet tea and nettle and used as an active ingredient.
本実施形態のメラニン取込抑制剤の患者に対する投与方法としては、皮下組織内投与、静脈内投与、経皮投与等が挙げられるが、疾患の種類に応じて、その予防・治療等に好適な方法を適宜選択すればよい。また、本実施形態のメラニン取込抑制剤の投与量も、疾患の種類、重症度、患者の個人差、投与方法、投与期間等によって適宜増減すればよい。 Examples of the method for administering the melanin uptake inhibitor of the present embodiment to a patient include subcutaneous tissue administration, intravenous administration, transdermal administration, and the like, but it is suitable for its prevention and treatment depending on the type of disease. A method may be selected as appropriate. In addition, the dosage of the melanin uptake inhibitor of this embodiment may be appropriately increased or decreased depending on the type of disease, severity, individual differences among patients, administration method, administration period, and the like.
本実施形態のメラニン取込抑制剤は、イロハモミジ、アスパラサスリネアリス、ガイヨウ、ウーロン茶、インチンコウ、オウゴン、アルニカ、セイヨウバラ、イチョウ、ジュウヤク、ビワ、ホップ、アセンヤク、甘茶及びイラクサからなる群より選ばれる1種又は2種以上の植物からの抽出物が有するメラニン取込抑制作用を通じて、表皮細胞(ケラチノサイト)の貪食作用(ファゴサイトーシス)によるメラニン(メラノソーム)の取り込みを抑制することができ、これにより皮膚の色黒(皮膚色素沈着症)、シミ、ソバカス等を予防、治療又は改善することができる。ただし、本実施形態のメラニン取込抑制剤は、これらの用途以外にもメラニン取込抑制作用を発揮することに意義のあるすべての用途に用いることができる。 The melanin uptake inhibitor of the present embodiment is 1 selected from the group consisting of Japanese maple, Asparasaslinearias, Guillain, Oolong tea, Inchinkou, Ogon, Arnica, Rosewood, Ginkgo, Jujuk, Biwa, Hop, Asenyaku, Sweet tea and Nettle. Through the melanin uptake-inhibiting action of seeds or extracts from two or more kinds of plants, the uptake of melanin (melanosomes) by phagocytosis (phagocytosis) of epidermal cells (keratinocytes) can be suppressed, thereby the skin Can prevent, treat or ameliorate the darkness (skin pigmentation), spots, buckwheat, and the like. However, the melanin uptake inhibitor of the present embodiment can be used for all purposes that are meaningful for exhibiting an action of inhibiting melanin uptake other than these uses.
なお、本実施形態のメラニン取込抑制剤は、ヒトに対して好適に適用されるものであるが、それぞれの作用効果が奏される限り、ヒト以外の動物に対して適用することもできる。 In addition, although the melanin uptake inhibitor of this embodiment is suitably applied to humans, it can also be applied to animals other than humans as long as each effect is exhibited.
以下、試験例を示し、本発明を具体的に説明するが、本発明は下記の各例に何ら制限されるものではない。なお、下記試験例においては、試料として、表1に示す製品の凍結乾燥品(試料1〜15)を使用した。 Hereinafter, although a test example is shown and this invention is demonstrated concretely, this invention is not restrict | limited to each following example at all. In the following test examples, lyophilized products (samples 1 to 15) shown in Table 1 were used as samples.
〔試験例1〕メラニン取込抑制作用試験
上記植物抽出物(試料1〜15)について、以下のようにメラニン取込抑制作用を試験した。
[Test Example 1] Melanin uptake inhibitory action test The above plant extracts (Samples 1 to 15) were tested for melanin uptake inhibitory action as follows.
ヒト正常新生児皮膚表皮角化細胞(NHEK)を、ヒト正常新生児表皮角化細胞用培地(KGM)を用いて培養した後、トリプシン処理により細胞を回収した。回収した細胞を2×105cells/mLの細胞密度になるようにKGMで希釈した後、コラーゲンコートした96ウェルプレートに100μLずつ播種し、一晩培養した。 Human normal neonatal skin epidermal keratinocytes (NHEK) were cultured using human normal neonatal epidermal keratinocyte medium (KGM), and then cells were collected by trypsin treatment. The collected cells were diluted with KGM to a cell density of 2 × 10 5 cells / mL, and then 100 μL each was seeded on a collagen-coated 96-well plate and cultured overnight.
培養終了後、培地を抜き、KGMに溶解した試料溶液(試料1〜15,試料濃度は下記表2を参照)を各ウェルに100μLずつ添加し、24時間培養した。培養終了後、擬似メラニンとしての赤色蛍光ビーズ(粒径:1.0μm,Fluorescent Microspheres, 580/605 nm; Molecular Probes社製)を3.6×107個/mLになるよう添加した0.5%BSA含有KGMを、各ウェルに100μLずつ添加し、4時間培養した。 After completion of the culture, the medium was removed, and 100 μL of a sample solution dissolved in KGM (samples 1 to 15; see Table 2 below for the sample concentration) was added to each well and cultured for 24 hours. After completion of the culture, red fluorescent beads (particle size: 1.0 μm, Fluorescent Microspheres, 580/605 nm; manufactured by Molecular Probes) as pseudo melanin were added to a concentration of 3.6 × 10 7 cells / mL. 100 μL of% BSA-containing KGM was added to each well and incubated for 4 hours.
培養終了後、培地を抜き、氷冷したKGM及びPBSで洗浄後、PBSを各ウェルに100μLずつ添加し、蛍光量を測定した。得られた測定結果から、下記式によりメラニン取込抑制率(%)を算出した。 After completion of the culture, the medium was removed, washed with ice-cooled KGM and PBS, and 100 μL of PBS was added to each well, and the amount of fluorescence was measured. From the obtained measurement results, the melanin uptake inhibition rate (%) was calculated by the following formula.
メラニン取込抑制率(%)=(1−A/B)×100
式中、Aは「試料添加時の蛍光量」を表し、Bは「試料無添加時の蛍光量」を表す。
結果を表2に示す。
Melanin uptake inhibition rate (%) = (1−A / B) × 100
In the formula, A represents “fluorescence amount at the time of sample addition”, and B represents “fluorescence amount at the time of no sample addition”.
The results are shown in Table 2.
表2に示すように、イロハモミジ、アスパラサスリネアリス、ガイヨウ、ウーロン茶、インチンコウ、オウゴン、アルニカ、セイヨウバラ、イチョウ、ジュウヤク、ビワ、ホップ、アセンヤク、甘茶及びイラクサからの抽出物は、いずれもメラニン取込抑制作用を有することが確認された。 As shown in Table 2, all the extracts from Japanese maple, asparagus linen alice, gaiyo, oolong tea, ginseng, dragonfly, arnica, rose, ginkgo, jujube, loquat, hop, asenyaku, sweet tea and nettle are all incorporated with melanin. It was confirmed to have an inhibitory action.
これらの中でも、イロハモミジ、アスパラサスリネアリス、ガイヨウ、ウーロン茶、インチンコウ、オウゴン、アルニカ及びアセンヤクからの抽出物は、優れたメラニン取込抑制作用を有しており、特に、イロハモミジ、アスパラサスリネアリス、ガイヨウ、ウーロン茶及びアセンヤクは、極めて優れたメラニン取込抑制作用を有していることが判明した。 Among these, the extracts from Japanese maple, Asparagus linen alice, gayyo, oolong tea, Inchinkou, Ogon, Arnica and Asenyaku have an excellent melanin uptake inhibitory action, Oolong tea and asenyaku were found to have an extremely excellent melanin uptake inhibitory effect.
本発明のメラニン取込抑制剤は、皮膚の色黒(皮膚色素沈着症)、シミ、ソバカス等の予防、治療又は改善に大きく貢献できる。 The melanin uptake inhibitor of the present invention can greatly contribute to the prevention, treatment or improvement of skin darkness (skin pigmentation), spots, buckwheat and the like.
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2009262309A JP2011105644A (en) | 2009-11-17 | 2009-11-17 | Melanin uptake inhibitor |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2009262309A JP2011105644A (en) | 2009-11-17 | 2009-11-17 | Melanin uptake inhibitor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2011105644A true JP2011105644A (en) | 2011-06-02 |
Family
ID=44229565
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009262309A Pending JP2011105644A (en) | 2009-11-17 | 2009-11-17 | Melanin uptake inhibitor |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2011105644A (en) |
Cited By (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2014122183A (en) * | 2012-12-21 | 2014-07-03 | Kose Corp | Dna damage inhibitor |
| JP2014132224A (en) * | 2013-01-04 | 2014-07-17 | Nagase & Co Ltd | Method for screening skin pigmentation inhibitor |
| JP2014162787A (en) * | 2013-02-28 | 2014-09-08 | Ichimaru Pharcos Co Ltd | Kinesin inhibitor |
| KR101441190B1 (en) * | 2012-08-06 | 2014-09-18 | 제주대학교 산학협력단 | Cosmetic composition containing Oreocnide fruticosa extraction |
| JP2014214139A (en) * | 2013-04-26 | 2014-11-17 | ポーラ化成工業株式会社 | Nadh production promoter |
| WO2015171475A1 (en) * | 2014-05-05 | 2015-11-12 | Access Business Group International Llc | Compositions including a botanical extract and methods of using the same in skin whitening and skin lightening applications |
| GB2562302A (en) * | 2017-05-12 | 2018-11-14 | Univ Pretoria | Aspalathus linearis extracts for melanin stimulation |
| CN111315353A (en) * | 2017-11-02 | 2020-06-19 | 科丝美诗生物有限公司 | Composition for improving human skin cell damage caused by ultraviolet rays, comprising hydrangea macrophylla extract |
| CN111388567A (en) * | 2019-01-02 | 2020-07-10 | 上海瑞帝安生物科技有限公司 | A kind of Chinese herbal medicine composition, cosmetic and preparation method for preventing ultraviolet and blue light |
| JP2022058065A (en) * | 2020-09-30 | 2022-04-11 | 株式会社ピカソ美化学研究所 | Actin reorganization inhibitor, phagocytosis inhibitor, stain formation inhibitor containing the inhibitor, and external skin preparation containing the inhibitor. |
| KR20230147474A (en) * | 2022-04-14 | 2023-10-23 | 경북대학교 산학협력단 | Composition for preventing or improving skin aging or skin pigmentation comprising desmethylxanthohumol as an active ingredient |
Citations (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH05139950A (en) * | 1991-11-26 | 1993-06-08 | Pola Chem Ind Inc | Cosmetic |
| JPH08175958A (en) * | 1994-12-27 | 1996-07-09 | Kao Corp | Topical skin |
| JPH10287543A (en) * | 1997-04-11 | 1998-10-27 | Yakult Honsha Co Ltd | Pigmentation inhibitor, skin cosmetic and skin external preparation containing the same |
| JPH10316550A (en) * | 1997-05-13 | 1998-12-02 | Kao Corp | Cosmetics |
| JPH1129430A (en) * | 1997-05-14 | 1999-02-02 | Kao Corp | Cosmetics |
| JPH11116429A (en) * | 1997-10-13 | 1999-04-27 | Mikimoto Pharmaceut Co Ltd | Cosmetic stock and cosmetic |
| JPH11180852A (en) * | 1997-12-22 | 1999-07-06 | Kanebo Ltd | Skin cosmetic |
| JPH11228339A (en) * | 1998-02-13 | 1999-08-24 | Ichimaru Pharcos Co Ltd | Melanin generation suppresser and preparation for external use for skin |
| JP2000229828A (en) * | 1999-02-05 | 2000-08-22 | Kose Corp | Skin bleaching lotion |
| JP2001181173A (en) * | 1999-12-27 | 2001-07-03 | Kose Corp | Bleaching preparation for external use |
| JP2002029959A (en) * | 2000-07-19 | 2002-01-29 | Shiseido Co Ltd | Skin care agent for bleaching skin |
| JP2002212052A (en) * | 2001-01-15 | 2002-07-31 | Hajime Ito | External preparation |
| JP2002212060A (en) * | 2001-01-18 | 2002-07-31 | Tsumura & Co | Cleaning composition |
| JP2002275081A (en) * | 2001-03-21 | 2002-09-25 | Kose Corp | Skin care preparation |
| JP2003300859A (en) * | 2002-02-05 | 2003-10-21 | Kose Corp | Skin care preparation |
| JP2004149500A (en) * | 2002-11-01 | 2004-05-27 | Noevir Co Ltd | Water-based stick-like bleaching composition |
| JP2005023042A (en) * | 2003-07-04 | 2005-01-27 | Noevir Co Ltd | External preparation for skin |
| JP2005139070A (en) * | 2003-11-04 | 2005-06-02 | Kanebo Cosmetics Inc | Skin cosmetics |
| JP2005336113A (en) * | 2004-05-27 | 2005-12-08 | Kao Corp | Skin cosmetics |
| JP2006137679A (en) * | 2004-11-10 | 2006-06-01 | Ichimaru Pharcos Co Ltd | Demelanizing agent having diaryl heptanoid derivative as active ingredient, skin external preparation and application to food and drink |
| JP2007269705A (en) * | 2006-03-31 | 2007-10-18 | Naris Cosmetics Co Ltd | c-kit GENE EXPRESSION INHIBITOR |
| JP2009096768A (en) * | 2007-10-18 | 2009-05-07 | Shiseido Co Ltd | Ligament cell activator |
-
2009
- 2009-11-17 JP JP2009262309A patent/JP2011105644A/en active Pending
Patent Citations (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH05139950A (en) * | 1991-11-26 | 1993-06-08 | Pola Chem Ind Inc | Cosmetic |
| JPH08175958A (en) * | 1994-12-27 | 1996-07-09 | Kao Corp | Topical skin |
| JPH10287543A (en) * | 1997-04-11 | 1998-10-27 | Yakult Honsha Co Ltd | Pigmentation inhibitor, skin cosmetic and skin external preparation containing the same |
| JPH10316550A (en) * | 1997-05-13 | 1998-12-02 | Kao Corp | Cosmetics |
| JPH1129430A (en) * | 1997-05-14 | 1999-02-02 | Kao Corp | Cosmetics |
| JPH11116429A (en) * | 1997-10-13 | 1999-04-27 | Mikimoto Pharmaceut Co Ltd | Cosmetic stock and cosmetic |
| JPH11180852A (en) * | 1997-12-22 | 1999-07-06 | Kanebo Ltd | Skin cosmetic |
| JPH11228339A (en) * | 1998-02-13 | 1999-08-24 | Ichimaru Pharcos Co Ltd | Melanin generation suppresser and preparation for external use for skin |
| JP2000229828A (en) * | 1999-02-05 | 2000-08-22 | Kose Corp | Skin bleaching lotion |
| JP2001181173A (en) * | 1999-12-27 | 2001-07-03 | Kose Corp | Bleaching preparation for external use |
| JP2002029959A (en) * | 2000-07-19 | 2002-01-29 | Shiseido Co Ltd | Skin care agent for bleaching skin |
| JP2002212052A (en) * | 2001-01-15 | 2002-07-31 | Hajime Ito | External preparation |
| JP2002212060A (en) * | 2001-01-18 | 2002-07-31 | Tsumura & Co | Cleaning composition |
| JP2002275081A (en) * | 2001-03-21 | 2002-09-25 | Kose Corp | Skin care preparation |
| JP2003300859A (en) * | 2002-02-05 | 2003-10-21 | Kose Corp | Skin care preparation |
| JP2004149500A (en) * | 2002-11-01 | 2004-05-27 | Noevir Co Ltd | Water-based stick-like bleaching composition |
| JP2005023042A (en) * | 2003-07-04 | 2005-01-27 | Noevir Co Ltd | External preparation for skin |
| JP2005139070A (en) * | 2003-11-04 | 2005-06-02 | Kanebo Cosmetics Inc | Skin cosmetics |
| JP2005336113A (en) * | 2004-05-27 | 2005-12-08 | Kao Corp | Skin cosmetics |
| JP2006137679A (en) * | 2004-11-10 | 2006-06-01 | Ichimaru Pharcos Co Ltd | Demelanizing agent having diaryl heptanoid derivative as active ingredient, skin external preparation and application to food and drink |
| JP2007269705A (en) * | 2006-03-31 | 2007-10-18 | Naris Cosmetics Co Ltd | c-kit GENE EXPRESSION INHIBITOR |
| JP2009096768A (en) * | 2007-10-18 | 2009-05-07 | Shiseido Co Ltd | Ligament cell activator |
Cited By (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101441190B1 (en) * | 2012-08-06 | 2014-09-18 | 제주대학교 산학협력단 | Cosmetic composition containing Oreocnide fruticosa extraction |
| JP2014122183A (en) * | 2012-12-21 | 2014-07-03 | Kose Corp | Dna damage inhibitor |
| JP2014132224A (en) * | 2013-01-04 | 2014-07-17 | Nagase & Co Ltd | Method for screening skin pigmentation inhibitor |
| JP2014162787A (en) * | 2013-02-28 | 2014-09-08 | Ichimaru Pharcos Co Ltd | Kinesin inhibitor |
| JP2014214139A (en) * | 2013-04-26 | 2014-11-17 | ポーラ化成工業株式会社 | Nadh production promoter |
| US9801809B2 (en) | 2014-05-05 | 2017-10-31 | Access Business Group International Llc | Compositions including a botanical extract and methods of using the same in skin whitening and skin lightening applications |
| WO2015171475A1 (en) * | 2014-05-05 | 2015-11-12 | Access Business Group International Llc | Compositions including a botanical extract and methods of using the same in skin whitening and skin lightening applications |
| GB2562302A (en) * | 2017-05-12 | 2018-11-14 | Univ Pretoria | Aspalathus linearis extracts for melanin stimulation |
| CN111315353A (en) * | 2017-11-02 | 2020-06-19 | 科丝美诗生物有限公司 | Composition for improving human skin cell damage caused by ultraviolet rays, comprising hydrangea macrophylla extract |
| CN111315353B (en) * | 2017-11-02 | 2021-08-13 | 科丝美诗生物有限公司 | Composition for ameliorating human skin cell damage caused by ultraviolet rays containing extract |
| CN111388567A (en) * | 2019-01-02 | 2020-07-10 | 上海瑞帝安生物科技有限公司 | A kind of Chinese herbal medicine composition, cosmetic and preparation method for preventing ultraviolet and blue light |
| JP2022058065A (en) * | 2020-09-30 | 2022-04-11 | 株式会社ピカソ美化学研究所 | Actin reorganization inhibitor, phagocytosis inhibitor, stain formation inhibitor containing the inhibitor, and external skin preparation containing the inhibitor. |
| KR20230147474A (en) * | 2022-04-14 | 2023-10-23 | 경북대학교 산학협력단 | Composition for preventing or improving skin aging or skin pigmentation comprising desmethylxanthohumol as an active ingredient |
| KR102750943B1 (en) | 2022-04-14 | 2025-01-09 | 경북대학교 산학협력단 | Composition for preventing or improving skin aging or skin pigmentation comprising desmethylxanthohumol as an active ingredient |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011105644A (en) | Melanin uptake inhibitor | |
| JP2009132662A (en) | Glutathione production promoter | |
| JP2009256272A (en) | Atp production promoting agent and epidermal cell activation agent | |
| JP2009256270A (en) | Insulin-like growth factor-1 expression promoting agent | |
| JP5137457B2 (en) | Stem cell growth factor expression increase inhibitor | |
| JP2009256244A (en) | Claudin production promoter, occludin production promoter and skin barrier function-improving agent | |
| CN108403495B (en) | Camellia extract and Chinese herbal medicine cosmetic containing camellia extract | |
| KR20090055309A (en) | Skin cosmetic composition for skin whitening and wrinkle improvement | |
| KR20080090806A (en) | Cosmetic composition having extract of natural product and having skin improvement effect | |
| JP2011020965A (en) | Cosmetic kit, and method of makeup | |
| KR20130030032A (en) | Cosmetic compositions comprising extracts of hubs | |
| Barua et al. | A review on effective utilization, phytochemical compounds, pharmacological intervention of a popularly used plant for developing a new drug: Zanthoxylum armatum with reference to its anticancer activity | |
| JP2009040757A (en) | Agent promoting laminin 5 production, agent normalizing dermal basement membrane, and agent promoting recovery of skin lesion | |
| JP2009256271A (en) | AQUAPORIN 3 mRNA EXPRESSION PROMOTOR AND SKIN MOISTURE RETENTION FUNCTION-IMPROVING AGENT | |
| JP2014221739A (en) | Type vii collagen expression promoter | |
| KR102012872B1 (en) | High concentrate for beverage containing black raspberry, plantaginis asiatica l., schizandra chinensis, lycii fructus and torilis japonica decandolle and the high concentrate for beverage prepared from the same | |
| KR100989944B1 (en) | A mixed herb medicine extracts having antioxidant whitening activity | |
| KR20180137952A (en) | Mask pack | |
| CN111053937A (en) | Plant-extracted household deodorizing and deodorizing disinfection composition and preparation method thereof | |
| JP2021031417A (en) | Transglutaminase-1 production promoter | |
| KR100984284B1 (en) | Hair tonic composition containing sewage, maca and mistletoe extract | |
| JP5896618B2 (en) | Melanin production inhibitor | |
| JP2015086168A (en) | Lipase inhibitor, and skin cosmetic for sebum control | |
| KR100747415B1 (en) | Cosmetic composition containing extract mixture having effect of alleviating female breast | |
| KR102289943B1 (en) | Cosmetic composition containing complex extracts of Chrysanthemum Sibiricum, Viscum Album, Selaginella Tamariscina, Portulaca Oleracea and Perilla Frutescens |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20121025 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20131112 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20131127 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20140402 |